Search for: "Hospira" Results 101 - 120 of 487
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2012, 1:50 pm by bill_h
Recently an influx of potential glass shard contamination prompted Hospira Inc to issue a voluntary recall on many of it’s injections. [read post]
2 Sep 2021, 9:15 am by IPWatchdog
Belcher brought the suit against Hospira, Inc. for infringement of the ‘197 patent under the Hatch-Waxman Act, but the district court found that the Belcher Chief Science Officer withheld... [read post]
28 Sep 2008, 3:26 am
Braun, Baxter and Hospira firms are selling similar types of eye wash without federal validation of their safety and effectiveness. [read post]
17 Aug 2012, 8:44 pm by Patent Docs
As part of an ongoing forum to bring researchers from universities and companies together to exchange ideas, discuss challenges, and explore potential collaborations to promote commercialization, Catalyzing Collaboration Between Industry and Academia in the Life Sciences will be offering a forum entitled "Focus on Biologics and Biosimilars" on September 28, 2012 from 8:00 am to 5:15 pm (Central) at Hospira, Inc. in Lake Forest, IL. [read post]
3 Jul 2011, 8:40 am by brian
Earlier in 2011, Hospira Inc., the sole U.S. manufacturer of sodium thiopental, announced that it will no longer manufacture the drug, forcing states to search for alternative sources or alternative drugs for their lethal injection protocols. [read post]
20 Oct 2009, 7:28 pm by Jeff Lowe
., and Hospira Inc., have reported 122 incidents of fires, sparks or charring from power cords used with their devices, which include infusion pumps and adult feeding tubes. [read post]
3 Aug 2016, 7:17 am by Brian Cordery
Hospira’s case on obviousness relied on prior art which disclosed trastuzumab was in phase II clinical trials for the treatment of breast cancer. [read post]
19 Dec 2013, 4:56 pm
 Priority is a good thing but only if you have it, as today's Court of Appeal decision in Novartis v Hospira [2013] EWCA Civ 1663 demonstrates. [read post]
12 Feb 2011, 10:35 am by Terry Lenamon / Reba Kennedy
Scheduling executions for various states in this country continues to be in flux, primarily due to this continuing problem of having Hospira exit the marketplace as the supplier of sodium thiopental, a necessary component to the three-drug lethal injection method of execution. [read post]
30 Mar 2020, 9:08 pm by Patent Docs
Patent No. 7,892,549 (claims 1–17) and was brought (in separate petitions consolidated after institution) by Hospira, Samsung Bioepsis,... [read post]
2 Sep 2021, 9:15 am by IPWatchdog
Belcher brought the suit against Hospira, Inc. for infringement of the ‘197 patent under the Hatch-Waxman Act, but the district court found that the Belcher Chief Science Officer withheld material information from the U.S. [read post]
10 Jun 2013, 5:23 am by Bexis
Hospira, Inc., No. 12-14078, slip op. [read post]
6 Jun 2017, 9:04 pm by Patent Docs
By Andrew Williams -- On May 25, 2017, the FDA's Oncologic Drug Advisory Committee recommended approval of biologics license application ("BLA") 125545 submitted by Hospira Inc., a Pfizer company, for Retacrit, a proposed biosimilar to Amgen Inc.'s Epogen/Procrit (epoetin alfa). [read post]